Among three recognised clinical phenotypes, type 3a Gaucher's disease is characterised by mild to severe systemic disease, neurological manifestations and myoclonic seizures. We report the long term clinical and electrophysiological follow-up of a 27-year old man with a diagnosis of type 3a Gaucher's disease, which was confirmed by bone marrow biopsy examination and leukocyte glucocerebrosidase level measurement. His neurological examination was normal throughout the follow-up period. EEG examination, recorded five days after the first seizure, revealed generalised nonrhythmic paroxysmal rapid spikes with occipital predominance increased by photic stimulation and normal background activity. The frequency of seizures increased from 3-4/year to 1-2/month within a follow-up period of 12 years and a repeat EEG examination on the eight year of diagnosis revealed additional background slowing. A giant potential was obtained in somatosensory evoked potential (SEP) examination. EEG findings of this case demonstrate a specific pattern with rapid spike activity, photosensitivity, eye closure sensitivity and gradual background slowing.
INTRODUCTION
Gaucher's disease is an autosomal recessive disorder caused by deficiency of glucocerebrosidase and is the most prevalent lysosomal storage disorder. According to a widely accepted classification clinical findings are divided into three groups.
The third type, also called the juvenile form, represents a more heterogeneous clinical status and patients may present with varying degrees of neurological and systemic manifestations. This type has therefore been divided into two subgroups (3a and 3b). In type 3a, patients exhibit a clinical picture which may be identical to progressive myoclonic epilepsy, with or without horizontal supranuclear gaze palsy, and mild systemic findings. We report the peculiar clinical and electroencephalographic (EEG) findings, in a case of type 3a Gaucher's disease, followed for 12 years.
CASE REPORT
A 27-year old man was healthy until 14 years of age, when he was discovered to have an enlarged liver during physical examination performed for symptoms of stomach ache, nausea and loss of appetite. He was diagnosed as having Gaucher's disease by bone marrow biopsy. Serum acid phosphatase level, biochemistry and blood count profiles were all normal throughout his follow-up period.
The patient began to have generalised seizures during sleep at the age of 15. All EEG recordings were obtained with the 10-20 standard electrode placement and included awake-alert record, photic stimulation, hyperventilation activation. EEG examination recorded five days after the first seizure (1986) revealed generalised nonrhythmic paroxysmal rapid spikes (6-8 Hz) with marked occipital predominance increased by photic stimulation and normal background activity (Fig. 1) . Similar findings were recorded in the second EEG examination (1986) after a six months seizure free period and stable clinical status (Fig. 2) . The frequency of spikes increased in harmony with the frequency of flicker (up to 30 Hz) and spikes frequently occurred on eye closure (Figs 1 and 2). Hyperventilation, also, seemed to create a slight augmentation in the frequency but the effect of photic stimulation was much more prominent. He con- tinued to have rare seizures (3-4/year) and there was no marked difference in any of his seven consecutive EEG examinations performed at changing intervals. A repeat EEG examination on the eighth year of diagnosis (1994) revealed additional background slowing, which persisted in all of his following control recordings (Fig. 3) . The frequency of seizures increased in the eleventh year of follow-up after a seizure free period of two years without any known predisposing factor and he began to have one or two seizures per month despite triple antiepileptic therapy with adequate doses and blood levels. All of the convulsions were of a nocturnal generalised tonic clonic type and there was no reported myoclonus.
He was hospitalised in February 1998 and April 1998 because of increased frequency of seizures (5-7 per month) and status epilepticus respectively. Daytime seizures began to appear at this time. Neurological examination was unremarkable except for a borderline mental status with an intelligence quotient of 82. The patient and his family denied any apparent intellectual decline noticeable in his daily life. Visual Evoked Potential examination (VEP) and cranial MRI examinations were normal. N20 and P25 wave amplitudes were found to be increased on SEP examination. Leukocyte glucocerebrosidase level (2.4 mmol/hour mg protein) was below normal levels.
DISCUSSION
Type 1 Gaucher's disease (chronic nonneuronopathic form) may present at any age with serious systemic manifestations but usually without neurological findings. Type 2 (acute neuronopathic form) patients exhibit an extensive involvement of the central nervous system together with systemic findings. Those patients that can not be included in the above categories are classified as having type 3 (subacute neuronopathic form) Gaucher's disease [1] [2] [3] .
This third type, also called the juvenile form, represents a more heterogeneous clinical status and patients may present with varying degrees of neurological and systemic manifestations [4] [5] [6] . This type has therefore been divided into two subgroups (3a and 3b). In type 3a, patients exhibit a clinical picture, which may be identical to progressive myoclonic epilepsy with or without horizontal supranuclear gaze palsy and mild systemic findings. The findings in our case fit this type with very mild systemic disease, epilepsy and EEG abnormalities. However, he has no myoclonic activity except in the eyelids.
There are few reports on the EEG findings of Gaucher's disease. Listed abnormalities in type 3 are background slowing with generalised epileptiform discharges, marked photosensitivity and multiple spike bursts prominent over the posterior regions [7] [8] [9] . EEG findings in our case demonstrate a similar pattern with rapid spike activity, photosensitivity in harmony with the flicker frequency, gradual background slowing. These findings seem to be specific for this type of disease. Another interesting finding in our case is eye closure sensitivity, which has not been described previously in other Gaucher's disease patients. This case is of particular importance in having significant and abundant abnormal EEG findings even in the earliest stages of disease, despite lack of severe neurological involvement. The patient currently continues to lead his life without any problems and his somatic and mental neurological status does not seem to be grossly affected. The photoconvulsive response is one of the hallmarks of the EEG findings in this pathological condition and has been previously assumed to be associated with the involvement of thalamocortical projections and the reticular activating system. This phenomenon may therefore be consistent with early involvement of these pathways together with the relative sparing of other central nervous system structures, especially cortical layers. This presumption warrants further pathological and electrophysiological assessment.
Nevertheless, seizure frequency seems to be a poor indicator of the clinical status of Gaucher's disease, as revealed in our case by severe EEG findings recorded after a seizure free period of six months and physicians should be alert for the presence of a serious cerebral disease, despite lack of frequent seizures.
